You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ro7247669

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • RO7247669
  • +2 more
  • (no location specified)
May 2, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

NSCLC Trial in Worldwide (RO7247669, Pembrolizumab, Paclitaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • RO7247669
  • +4 more
  • Benowa, Queensland, Australia
  • +6 more
Mar 16, 2023

Melanoma Trial in North Sydney, Woolloongabba, Wellington (RO7247669)

Recruiting
  • Melanoma
  • RO7247669
  • North Sydney, New South Wales, Australia
  • +12 more
Jan 30, 2023

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • RO7247669
  • +3 more
  • Beijing, China
  • +1 more
Mar 28, 2023

Solid Tumors, Metastatic Melanoma, NSCLC Trial in Worldwide (RO7247669)

Recruiting
  • Solid Tumors
  • +3 more
  • RO7247669
  • San Diego, California
  • +20 more
Aug 19, 2022

Melanoma Trial in Worldwide (Nivolumab, Ipilimumab, RO7247669)

Recruiting
  • Melanoma
  • Duarte, California
  • +20 more
Jan 24, 2023

Advanced or Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (RO7121661, RO7247669, Nivolumab)

Recruiting
  • Advanced or Metastatic Esophageal Squamous Cell Carcinoma
  • Buenos Aires, Argentina
  • +79 more
Aug 3, 2022